Traditional Chinese medicine composition for treating viral pneumonia and application thereof

By developing a traditional Chinese medicine composition containing drugs such as honeysuckle, chrysanthemum, and big green leaves, to address the symptoms of viral pneumonia epidemic and dryness, the problems of insufficient clearing heat and detoxification and failure to effectively alleviate the symptoms of dry evil and detoxification in the prior art have been solved. , effective treatment and symptoms of viral pneumonia have been achieved.

CN118924847APending Publication Date: 2024-11-12YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411082864.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-08-24
Filing Date
2024-08-08
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art has difficulties such as strong viral variability and lack of special drugs when treating viral pneumonia. Traditional Chinese patent medicines lack heat clearance and detoxification, and cannot effectively relieve symptoms related to dry cough, dry mouth, constipation, and other dry evil and body deficiency.

Method used

Develop a traditional Chinese medicine composition, including honeysuckle, chrysanthemum, big green leaves, mint, reed root, wolfberry, tangerine peel, rose and astragalus, etc., through the effects of clearing heat and detoxifying, relieving wind and moistening dryness, etc., it targets viral pneumonia epidemics. The symptoms of patients with dry syndrome are combined with traditional Chinese medicine theory and clinical experience to make new Chinese medicine preparations with exact efficacy, safe and effective treatment.

Benefits of technology

Effectively alleviate the symptoms of patients with dry syndrome of viral pneumonia, improve symptoms such as dry cough, sore throat, dry mouth, constipation, improve clinical efficacy, reduce the course of the disease and the incidence of critical illness, and have no obvious adverse reactions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004984282490000081
    Figure BDA0004984282490000081
  • Figure BDA0004984282490000082
    Figure BDA0004984282490000082
  • Figure BDA0004984282490000091
    Figure BDA0004984282490000091
Patent Text Reader

Abstract

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating viral pneumonia and application, and the traditional Chinese medicine composition comprises the following raw material medicines in parts by weight: 3-30 parts of honeysuckle, 3-12 parts of chrysanthemum, 3-15 parts of folium isatidis, 3-12 parts of mint, 9-60 parts of rhizoma phragmitis, 3-18 parts of wolfberry, 3-15 parts of pericarpium citri reticulatae, 3-18 parts of rose, 9-60 parts of astragalus membranaceus and 3-12 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention is precise and appropriate in compatibility, has the effects of clearing away heat and toxic materials, dispelling wind and moistening dryness and the like, effectively relieves symptoms and related multiple physiological indexes of a patient suffering from viral pneumonia virus dryness syndrome, and has an exact curative effect. Under the guidance of traditional Chinese medicine theories and clinical experience, all the raw material medicines and proportions are selected, the pure traditional Chinese medicine preparation is adopted, no toxic or side effect exists, the aim of treating viral pneumonia patients is achieved, and the patient acceptability is high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating viral pneumonia and its clinical application. Background Art

[0002] Viral pneumonia is a disease caused by viruses invading the respiratory epithelium and alveolar epithelial cells, which causes inflammation of the lung interstitium and parenchyma, leading to pulmonary ventilation dysfunction. The main clinical manifestations are fever, headache, body aches, dry cough and lung infiltration. The disease is highly contagious and the course of disease progresses rapidly. Individuals with normal or suppressed immune function can suffer from it. Most of them occur in winter and spring, and can be seen in sporadic epidemics or population outbreaks. Viruses are another common pathogen of community-acquired pneumonia (CAP) in adults besides bacteria, and most of them can heal on their own.

[0003] With the development and application of virus detection technology, the status of respiratory viruses in the etiology of adult CAP has gradually received attention. They can be the direct pathogens of CAP, and can also make patients susceptible to secondary bacterial pneumonia such as Streptococcus pneumoniae and Staphylococcus aureus; primary viral pneumonia, secondary or combined bacterial infection are not without severe cases. At present, the treatment of viral pneumonia includes antiviral, immunomodulatory, hormones, symptomatic support, etc., but there are difficulties in treatment such as strong viral variability and lack of specific drugs.

[0004] Viral pneumonia is mainly caused by a series of pathological changes caused by the failure of the lungs to descend and be affected by external pathogens on the basis of deficiency of the body. Most of the names of diseases in traditional Chinese medicine belong to the categories of "wind-heat", "epidemic", "cough", "asthma", etc., and the location of the disease is mostly attributed to the upper part of the body. As stated in "Suwen·Zhizhen Yaoda Lun Pian": "All paralysis, asthma and vomiting belong to the upper part", "All qi stagnation and depression belong to the lungs." There are many kinds of causes of its onset. Most patients with viral pneumonia have weak body functions and show deficiency of lung and spleen qi and deficiency of qi and yin, which makes them susceptible to external pathogens. The advantages of traditional Chinese medicine in improving the clinical efficacy of diseases, improving the quality of life of patients, enhancing the body's immune function and promoting health recovery have attracted more and more attention. The body's own immunity is the most important part in fighting viral pneumonia. The elimination of viruses ultimately depends on the body itself. Traditional Chinese medicine obviously pays attention to this point. It can regulate the body's immune function, stimulate the body's own disease resistance, promote the repair of diseased tissues, and achieve the effect of combining expelling evil and strengthening the body. In terms of antiviral treatment, on the one hand, it can directly inhibit the virus, and on the other hand, it can regulate the body's immune system to play an antiviral immune regulatory role, thereby eliminating the virus. It has the characteristics of multiple components, multiple targets, and multiple pathways. Traditional Chinese medicine uses syndrome differentiation and treatment in the treatment of viral pneumonia, which is tailored to the individual. The initial intervention of traditional Chinese medicine can not only shorten the course of the disease and reduce the incidence of viral pneumonia developing into critical illness, but also reduce its sequelae and improve clinical efficacy. Summary of the invention

[0005] The purpose of the present invention is to provide a Chinese medicine composition for treating viral pneumonia and its application in view of the deficiencies in the prior art.

[0006] The present invention is a clinical experience prescription prepared by experts of the Department of Respiratory Medicine of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine on the basis of clinical treatment of respiratory diseases of wind-dryness injury to the lungs, and based on the symptoms of patients with viral pneumonia, and based on the classic prescriptions such as Sangjuyin and Yinqiaosan. It effectively alleviates the symptoms of patients with viral pneumonia and epidemic toxin-dryness syndrome, and has a definite therapeutic effect. Therefore, it is of great clinical and scientific value to find and develop new Chinese medicine preparations with refined formula, definite efficacy, safety and effectiveness from traditional Chinese medicine for the treatment of viral pneumonia.

[0007] The first aspect of the present invention provides a traditional Chinese medicine composition for treating viral pneumonia, which is prepared from the following raw materials in parts by weight: 3-30 parts of honeysuckle, 3-15 parts of chrysanthemum, 3-15 parts of isatis indigotica, 3-12 parts of mint, 9-60 parts of reed roots, 3-18 parts of wolfberry, 3-15 parts of tangerine peel, 3-18 parts of rose, 9-60 parts of astragalus, and 3-12 parts of licorice.

[0008] Furthermore, the Chinese medicine composition is made of the following raw materials in parts by weight: 6-18 parts of honeysuckle, 6-12 parts of chrysanthemum, 6-12 parts of isatis indigotica, 3-9 parts of mint, 12-30 parts of reed root, 6-15 parts of wolfberry, 6-15 parts of tangerine peel, 3-12 parts of rose, 12-30 parts of astragalus, and 3-9 parts of licorice.

[0009] Furthermore, the Chinese medicine composition is made of the following raw materials in parts by weight: 12 parts of honeysuckle, 9 parts of chrysanthemum, 6 parts of isatis indigotica, 3 parts of mint, 15 parts of reed root, 15 parts of wolfberry, 9 parts of tangerine peel, 3 parts of rose, 15 parts of astragalus, and 3 parts of licorice.

[0010] The second aspect of the present invention provides a use of the above-mentioned traditional Chinese medicine composition in the preparation of a drug for the treatment of viral pneumonia.

[0011] Furthermore, the viral pneumonia has the following clinical manifestations: ① fever and (or) respiratory symptoms and other clinical manifestations related to viral pneumonia; ② the above-mentioned imaging characteristics of viral pneumonia; ③ the total white blood cell count is normal or decreased in the early stage of the disease, the lymphocyte count is normal or decreased, and there is viral etiology or serological evidence and epidemiological history. At the same time, pneumonia manifestations can be seen in imaging.

[0012] Furthermore, the viral pneumonia treatment drug refers to a treatment drug for viral pneumonia with toxic and dryness syndrome.

[0013] Furthermore, the viral pneumonia therapeutic drug refers to a drug that improves symptoms such as sore throat, itchy throat, chills, dry cough, nasal congestion, runny nose, fever, dry or difficult stool, dry mouth, and muscle aches in patients with viral pneumonia.

[0014] The third aspect of the present invention provides a pharmaceutical preparation having the above-mentioned Chinese medicine composition for treating viral pneumonia as an active ingredient, wherein the pharmaceutical preparation is prepared into a commonly used dosage form in pharmacy by conventional preparation methods in the art.

[0015] Furthermore, the pharmaceutical preparation is an oral preparation, including decoction, tablet, capsule, granule, mixture, pill, oral liquid or syrup.

[0016] Furthermore, the pharmaceutical preparation also includes pharmaceutically acceptable excipients, including: emulsifiers, excipients, fillers, binders, wetting agents, disintegrants, absorption promoters, flavoring agents, colorants, cosolvents or water, etc.; fillers such as starch, sucrose, lactose, microcrystalline cellulose, etc.; binders such as cellulose derivatives, alginates, gelatin and polyvinyl pyrrolidone; wetting agents such as glycerol; disintegrants such as sodium carboxymethyl starch, hydroxypropyl cellulose, cross-linked carboxymethyl cellulose, agar, calcium carbonate and sodium bicarbonate; absorption promoters such as quaternary ammonium compounds; surfactants such as cetyl alcohol and sodium lauryl sulfate; adsorption carriers such as kaolin and soap clay; lubricants such as talc, calcium and magnesium stearate, micropowdered silica gel and polyethylene glycol, etc.

[0017] The fourth aspect of the present invention provides a use of the pharmaceutical preparation as described above in the preparation of a drug for the treatment of viral pneumonia.

[0018] The mechanism of action of the Chinese medicine composition of the present invention is as follows: honeysuckle and chrysanthemum in the prescription are both lung meridian and good at ascending to the upper part of the body, and are the main medicines for clearing away heat and detoxifying; mint is used to match the main medicine chrysanthemum to dispel wind and heat and eliminate external evil, and isatis indigotica enhances the effect of clearing away heat and detoxifying of the whole prescription, and mint and isatis indigotica are the ministerial medicines, so that the heat evil of the exterior and interior can be cleared; reed root, wolfberry, astragalus, tangerine peel, and rose are all adjuvants, and heat toxins consume qi and hurt body fluids, among which reed root and wolfberry can promote body fluids and moisten the lungs and clear away heat, astragalus can invigorate qi and consolidate the exterior, support the positive energy, and prevent the internal invasion of evil toxins, and at the same time, in order to prevent the stagnation of body fluids and qi, tangerine peel and rose are added to promote qi and eliminate dampness, and mobilize the whole body qi mechanism so that the medicine reaches the diseased area; liquorice is used to harmonize the various medicines. The above various medicines are used together to have the effects of clearing away heat and detoxifying, dispersing wind and moistening dryness, so they can play a good therapeutic effect on viral pneumonia.

[0019] Currently, the Chinese patent medicines on the market focus on the effects of clearing away heat and detoxifying, but lack the therapeutic effect in terms of heat evil damaging body fluid. The indications do not only include fever, chills, runny nose, muscle aches and other related symptoms caused by heat evil and epidemic toxins themselves, but cannot treat dry cough, dry mouth, constipation and other dryness evil and body fluid deficiency related symptoms. The Chinese medicine composition of the present invention is more targeted for patients with viral pneumonia epidemic toxins and dryness syndrome. The medicine focuses on clearing epidemic toxins and promoting body fluid and moistening dryness, which can improve the dry cough, sore throat, itchy throat, dry mouth and dry throat caused by epidemic toxins consuming qi and damaging body fluids to a certain extent, and no obvious adverse reactions are observed in clinical use, and patients have good tolerance. Ye Tianshi's "Warm Heat Theory" "Saving yin is not in blood, but in body fluid and sweat". Saving yin in febrile diseases does not lie in replenishing yin and blood, but in nourishing body fluid and not sweating indiscriminately. The ninth edition of the recommended prescription Xuanfei Runzao Jiedu recipe, in which ephedra has too strong diaphoretic and dispersing power, and Notopterygium wilfordii has a strong dryness, and these two medicines may damage body fluid and consume qi, while the mint and chrysanthemum in this product have a milder dispersing power and can better protect the body fluid and qi of the patient; qi can produce body fluid and qi can move body fluid, and the nourishment of body fluid to the human body depends on the distribution and promotion of qi, Xuanfei Runzao Jiedu recipe only provides products that nourish yin and produce body fluid, while the present invention also adds astragalus to enhance the qi-tonifying effect, and adds tangerine peel and rose to regulate qi and move qi, to prevent the risk of stagnation due to tonification.

[0020] Clinical observations show that many common symptoms of viral pneumonia include dry cough, itchy and sore throat, dry mouth and constipation, etc. The treatment is intended to clear away heat and moisten dryness. After treatment with the Chinese medicine composition of the present invention, the patient's symptoms are significantly relieved. After taking the medicine, the patient's symptoms are improved.

[0021] The present invention has the advantages that:

[0022] 1. The Chinese medicine composition of the present invention is well-matched and has the effects of clearing away heat and detoxifying, dispersing wind and moistening dryness, etc. It effectively alleviates the symptoms and related multiple physiological indicators of patients with viral pneumonia epidemic toxic and dryness syndrome, and has a definite therapeutic effect.

[0023] 2. It has few medicinal flavors, is easy to prepare, has abundant and readily available raw materials, is low in cost, and is suitable for promotion;

[0024] 3. The present invention is guided by traditional Chinese medicine theory and clinical experience, and selects various raw materials and proportions to achieve the purpose of treating patients with viral pneumonia. It uses pure Chinese medicine preparations, has no toxic side effects, and is easily accepted by patients. DETAILED DESCRIPTION

[0025] The specific implementation methods provided by the present invention are described in detail below in conjunction with examples.

[0026] Embodiment 1: Chinese medicine composition of the present invention

[0027] 12 parts of honeysuckle, 9 parts of chrysanthemum, 6 parts of isatis indigotica, 3 parts of mint, 15 parts of rhizoma phragmites, 15 parts of wolfberry fruits, 9 parts of dried orange peel, 3 parts of rose, 15 parts of astragalus, and 3 parts of liquorice.

[0028] Embodiment 2: Chinese medicine composition of the present invention

[0029] 15 parts of honeysuckle, 9 parts of chrysanthemum, 9 parts of isatis indigotica, 3 parts of mint, 18 parts of reed roots, 15 parts of wolfberries, 9 parts of dried orange peel, 6 parts of rose, 15 parts of astragalus, and 3 parts of liquorice.

[0030] Embodiment 3: Chinese medicine composition of the present invention

[0031] 15 parts of honeysuckle, 12 parts of chrysanthemum, 6 parts of isatis indigotica, 3 parts of mint, 15 parts of rhizoma phragmites, 15 parts of wolfberry fruits, 9 parts of dried orange peel, 3 parts of rose, 18 parts of astragalus, and 6 parts of liquorice.

[0032] Embodiment 4: Chinese medicine composition of the present invention

[0033] 18 parts of honeysuckle, 12 parts of chrysanthemum, 12 parts of isatis indigotica, 3 parts of mint, 30 parts of reed roots, 15 parts of wolfberries, 6 parts of dried orange peels, 3 parts of roses, 15 parts of astragalus, and 3 parts of liquorice.

[0034] Embodiment 5: Chinese medicine composition of the present invention

[0035] 18 parts of honeysuckle, 9 parts of chrysanthemum, 6 parts of isatis indigotica, 6 parts of peppermint, 15 parts of reed roots, 15 parts of wolfberries, 9 parts of dried orange peels, 6 parts of roses, 15 parts of astragalus, and 6 parts of liquorice.

[0036] Embodiment 6: Chinese medicine composition of the present invention

[0037] 12 parts of honeysuckle, 9 parts of chrysanthemum, 6 parts of isatis indigotica, 3 parts of mint, 30 parts of reed roots, 18 parts of wolfberries, 9 parts of dried orange peel, 3 parts of rose, 18 parts of astragalus, and 3 parts of liquorice.

[0038] Embodiment 7: Chinese medicine composition of the present invention

[0039] 12 parts of honeysuckle, 9 parts of chrysanthemum, 6 parts of isatis indigotica, 6 parts of peppermint, 15 parts of reed roots, 15 parts of wolfberries, 9 parts of dried orange peel, 9 parts of rose, 15 parts of astragalus, and 6 parts of liquorice.

[0040] Embodiment 8: Chinese medicine composition of the present invention

[0041] 21 parts of honeysuckle, 12 parts of chrysanthemum, 9 parts of isatis indigotica, 6 parts of mint, 30 parts of reed roots, 18 parts of wolfberries, 9 parts of dried orange peel, 6 parts of rose, 15 parts of astragalus, and 3 parts of liquorice.

[0042] Example 9: Chinese medicine composition of the present invention

[0043] 3 parts of honeysuckle, 3 parts of chrysanthemum, 3 parts of isatis indigotica, 3 parts of mint, 9 parts of reed roots, 3 parts of wolfberry, 3 parts of dried orange peel, 3 parts of rose, 9 parts of astragalus, and 3 parts of liquorice.

[0044] Embodiment 10: Chinese medicine composition of the present invention

[0045] 6 parts of honeysuckle, 6 parts of chrysanthemum, 6 parts of isatis indigotica, 6 parts of mint, 21 parts of reed roots, 6 parts of wolfberry fruits, 6 parts of dried orange peel, 9 parts of rose, 12 parts of astragalus, and 6 parts of liquorice.

[0046] Example 11: Chinese medicine composition of the present invention

[0047] 25 parts of honeysuckle, 12 parts of chrysanthemum, 9 parts of isatis indigotica, 9 parts of peppermint, 40 parts of rhizomes of phragmites, 12 parts of wolfberries, 12 parts of dried orange peels, 12 parts of roses, 30 parts of astragalus, and 9 parts of sweet potatoes.

[0048] Example 12: Chinese medicine composition of the present invention

[0049] 30 parts of honeysuckle, 15 parts of chrysanthemum, 15 parts of isatis indigotica, 12 parts of mint, 60 parts of reed roots, 18 parts of wolfberries, 15 parts of dried orange peels, 18 parts of roses, 60 parts of astragalus, and 12 parts of liquorice.

[0050] Example 13: Preparation of the Chinese medicine composition decoction of the present invention

[0051] The conventional preparation method of Chinese medicine decoction is adopted, that is, the Chinese medicine composition described in any one of Examples 1-12 is added with water and boiled into a decoction.

[0052] Example 14: Preparation of Chinese medicine composition tablets of the present invention

[0053] Weigh the Chinese medicine raw materials according to the ratio described in any one of Examples 1-12, add water and boil twice, each time for 1 hour, add 12 times the amount of water for the first time, and add 8 times the amount of water for the second time, filter the drug residue, combine the two filtrates, combine the aqueous solutions and concentrate them to a relative density of 1.05-1.06 (70°C), add ethanol to make the alcohol content reach 55%, let it stand, filter, recover the ethanol from the filtrate and concentrate it to a fluid extract with a relative density of 1.12-1.16 (60°C); mix the above-mentioned drug residue fine powder, inclusion compound, fluid extract and appropriate amount of excipients, granulate in one step, tablet press, and film coat to obtain.

[0054] Example 15: Preparation of the Chinese medicine composition granules of the present invention

[0055] Weigh the Chinese medicinal raw materials according to the ratio described in any one of Examples 1-12, add water and boil twice, each time for 1 hour, add 12 times the amount of water for the first time, and add 8 times the amount of water for the second time, filter the drug residue, combine the two filtrates, combine with the above aqueous solution and concentrate to a relative density of 1.05-1.06 (70°C), add ethanol to make the alcohol content reach 55%, let it stand, filter, recover ethanol from the filtrate and concentrate it to a fluid extract with a relative density of 1.12-1.16 (60°C); mix the above drug fine powder, inclusion compound, fluid extract and appropriate amount of auxiliary materials and granulate them in one step to obtain.

[0056] Example 16: Preparation of the Chinese medicine composition capsule of the present invention

[0057] Weigh the Chinese medicinal raw materials according to the ratio described in any one of Examples 1-12, add water and boil twice, each time for 1 hour, add 12 times the amount of water for the first time, and add 8 times the amount of water for the second time, filter the drug residue, combine the two filtrates, combine with the above aqueous solution and concentrate to a relative density of 1.05-1.06 (70°C), add ethanol to make the alcohol content reach 55%, let it stand, filter, recover ethanol from the filtrate and concentrate it to a fluid extract with a relative density of 1.12-1.16 (60°C); mix the above drug fine powder, inclusion compound, fluid extract and appropriate amount of excipients, and fill capsules to obtain.

[0058] Example 17: Preparation of the Chinese medicine composition / oral liquid / syrup of the present invention

[0059] Weigh the Chinese medicinal materials according to the ratio described in any one of Examples 1-12, add 8-10 times the amount of water, decoct for 3 hours, and filter out the medicinal juice. Add 8 times the amount of water again, decoct for 2 hours, filter out the medicinal juice, combine the two decoctions, let stand, filter out the supernatant, concentrate, cool, add 2 times the amount of alcohol of the concentrate, stir and precipitate overnight. Take the supernatant, concentrate to a thick extract; add appropriate pharmaceutical excipients to prepare a mixture, oral liquid or syrup.

[0060] Example 18: Clinical observation of the efficacy of the present invention in treating viral pneumonia

[0061] 1 General Information

[0062] 1.1 Case source

[0063] The Department of Infection and Respiratory Medicine of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine enrolled 90 cases of viral pneumonia with epidemic toxin and dryness syndrome from March 29, 2022 to May 17, 2022, including 52 males, accounting for 57.78%, and 38 females, accounting for 42.22%; the average age was 54.37 years old; 31 cases had a history of smoking, accounting for 34.44%; 32.22% of patients had underlying diseases (19 cases of hypertension, 7 cases of diabetes, and 3 cases of coronary heart disease and hypertension).

[0064] 1.2 Diagnostic criteria

[0065] 1.2.1 Western medicine diagnostic criteria

[0066] Refer to the diagnostic criteria for viral pneumonia in the "Guidelines for the Diagnosis and Treatment of Community-Acquired Pneumonia in Adults in China (2016 Edition)" and "Internal Medicine (9th Edition)":

[0067] (1) Clinical manifestations: fever and / or respiratory symptoms and other clinical manifestations related to viral pneumonia;

[0068] (2) having radiological features of viral pneumonia (bilateral, multilobar interstitial infiltration, ground-glass opacity, and possibly consolidation);

[0069] (3) In the early stage of the disease, the total white blood cell count is normal or decreased, the lymphocyte count is normal or decreased, and there is viral etiology or serological evidence and epidemiological history.

[0070] 1.2.2 TCM diagnostic criteria

[0071] The patient meets the criteria for viral pneumonia with toxic and dryness syndrome (clinical manifestations: aversion to cold, fever, muscle aches, runny nose, dry cough, sore throat, itchy throat, dry mouth and throat, constipation, pale tongue with little fluid, thin white or dry tongue coating, and floating and tight pulse).

[0072] 1.3 Inclusion criteria

[0073] (1) Patients who meet the above-mentioned Western medical diagnosis of viral pneumonia and meet the TCM syndrome differentiation of epidemic toxicity and dryness;

[0074] (2) Aged between 18 and 90, regardless of gender;

[0075] (3) The patient had not participated in any clinical trial research within 3 months before the trial;

[0076] (4) Fully understand this clinical study, sign the informed consent and cooperate with regular follow-up;

[0077] 1.4 Exclusion criteria

[0078] (1) Pneumonia caused by other pathogens;

[0079] (2) Those who are allergic to the drugs used;

[0080] (3) those who did not meet the inclusion criteria;

[0081] (4) Patients who have participated in clinical trial research within 12 weeks.

[0082] (5) Pregnant or breastfeeding women;

[0083] (6) Those who are considered unsuitable for inclusion in this trial by other researchers.

[0084] 2. Treatment options:

[0085] The enrolled patients were divided into a Chinese medicine treatment group and a basic treatment group, each with 45 cases. The Chinese medicine treatment group selected the Chinese medicine composition in the prescription amount of Example 1, the dosage was adjusted according to the symptoms, and the Chinese medicine pharmacy decocted it on behalf of the patient, one dose per day, taken in the morning and evening, 200 ml each time, and combined with basic treatment (including bed rest, oxygen inhalation, etc.). The basic treatment group used basic treatment alone.

[0086] 3. Observation indicators

[0087] 3.1 Efficacy indicators:

[0088] Observe the improvement of the patient's symptoms such as sore throat, itchy throat, aversion to cold, dry cough, nasal congestion, runny nose, fever, dry or difficult bowel movements, dry mouth, and muscle aches.

[0089] 3.2 Safety observation:

[0090] Pay attention to observe and report adverse reactions in a timely manner. Observation indicators include nausea, abdominal pain, vomiting and other symptoms.

[0091] 4. Efficacy evaluation

[0092] 4.1 Efficacy evaluation criteria:

[0093] Refer to the post-treatment evaluation criteria of the "Guidelines for the Diagnosis and Treatment of Community-Acquired Pneumonia in Adults in China (2016 Edition)"; Traditional Chinese Medicine symptoms include sore throat, itchy throat, aversion to cold, dry cough, nasal congestion, runny nose, fever, dry or difficult bowel movements, dry mouth, muscle aches, etc. as the efficacy evaluation criteria: ① Effective: symptoms disappear, ② Ineffective: symptoms do not improve or worsen.

[0094] 4.2 Evaluation method:

[0095] The number of cases and percentage of disappearance of TCM symptoms of sore throat and itchy throat, aversion to cold, dry cough, nasal congestion, runny nose, fever, dry or difficult bowel movements, dry mouth, and muscle aches.

[0096] 5. Results

[0097] 5.1 Symptom improvement

[0098] Table 1 Summary of clinical symptoms of patients in the Chinese medicine treatment group

[0099]

[0100] Table 2 Summary of clinical symptoms of patients in the basic treatment group

[0101]

[0102]

[0103] The difference in the effective rate of each symptom between the two groups was tested by paired chi-square test, and the difference was statistically significant (p < 0.01). The effective rate of each symptom in the Chinese medicine treatment group was better than that in the basic treatment group.

[0104] 5.2 Security Analysis

[0105] No adverse reactions such as nausea, vomiting, and abdominal pain were observed after oral administration of Chinese medicine.

[0106] 6. Conclusion

[0107] The Chinese medicine composition of the present invention can significantly improve the symptoms of pharyngitis, pharyngitis, aversion to cold, dry cough, nasal congestion, runny nose, fever, dry or difficult stool, dry mouth, muscle aches and the like in patients with viral pneumonia and epidemic toxic dryness syndrome, and has good clinical value.

[0108] The above is only a preferred embodiment of the present invention. It should be pointed out that ordinary technicians in this technical field can make several improvements and supplements without departing from the method of the present invention. These improvements and supplements should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicine composition for treating viral pneumonia, It is characterized in that The invention is prepared from the following raw materials in parts by weight: 3-30 parts of honeysuckle, 3-15 parts of chrysanthemum, 3-15 parts of isatis indigofera, 3-12 parts of mint, 9-60 parts of reed root, 3-18 parts of wolfberry, 3-15 parts of tangerine peel, 3-18 parts of rose, 9-60 parts of astragalus and 3-12 parts of liquorice.

2. The Chinese medicine composition according to claim 1, It is characterized in that The invention is prepared from the following raw materials in parts by weight: 6-18 parts of honeysuckle, 6-12 parts of chrysanthemum, 6-12 parts of isatis indigofera, 3-9 parts of mint, 12-30 parts of reed root, 6-15 parts of wolfberry, 6-15 parts of tangerine peel, 3-12 parts of rose, 12-30 parts of astragalus and 3-9 parts of liquorice.

3. The Chinese medicine composition according to claim 2, It is characterized in that The medicine is prepared from the following raw materials in parts by weight: 12 parts of honeysuckle, 9 parts of chrysanthemum, 6 parts of isatis indigotica, 3 parts of mint, 15 parts of reed root, 15 parts of wolfberry, 9 parts of tangerine peel, 3 parts of rose, 15 parts of astragalus, and 3 parts of liquorice.

4. Use of the Chinese medicine composition as claimed in any one of claims 1 to 3 in the preparation of a drug for treating viral pneumonia.

5. The use according to claim 4, It is characterized in that The viral pneumonia therapeutic drug is a therapeutic drug for viral pneumonia with toxic and dryness syndrome.

6. A pharmaceutical preparation comprising the Chinese medicine composition for treating viral pneumonia as claimed in any one of claims 1 to 3 as an active ingredient, It is characterized in that The pharmaceutical preparation is prepared into a common dosage form in pharmacy by conventional preparation methods in the art.

7. The pharmaceutical preparation according to claim 6, It is characterized in that The pharmaceutical preparation is an oral preparation; the oral preparation includes decoction, tablet, capsule, granule, mixture, pill, oral liquid or syrup.

8. The pharmaceutical preparation according to claim 7, It is characterized in that The medicine also includes pharmaceutically acceptable excipients.

9. The pharmaceutical preparation according to claim 8, It is characterized in that The pharmaceutically acceptable excipients include emulsifiers, excipients, fillers, binders, wetting agents, disintegrants, absorption enhancers, flavoring agents, colorants or solubilizers.

10. Use of the pharmaceutical preparation according to any one of claims 6 to 9 in the preparation of a drug for treating viral pneumonia.

Citation Information

Patent Citations

  • Health-care medicine for preventing and treating influenza and preparation method thereof

    CN101716226A